Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 5Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Mucositis 2Inflammation 2Diarrhea 2Chalazion 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Smoldering Multiple Myeloma 1Radiation Injuries 1Pelvic Neoplasms 1Pelvic Inflammatory Disease 1Neoplasms, Second Primary 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Malnutrition 1Liver Cirrhosis 1Laryngeal Neoplasms 1Infections 1Generalized Anxiety Disorder 1Fibrosis 1Fatigue Syndrome, Chronic 1Enteritis 1Endotoxemia 1Carcinogenesis 1

Interventions

Cyclophosphamide 18fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 11Antilymphocyte Serum 10fludarabine 9Exercise 9Busulfan 9Mycophenolic Acid 8Melphalan 8Dexamethasone 8Blood Specimen Collection 8Filgrastim 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6Therapeutics 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5Surveys and Questionnaires 4Stem Cell Transplantation 4Psychiatric Rehabilitation 4Practice Guidelines as Topic 4Methylprednisolone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Multiple Myeloma × Probiotics × Clear all
NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
200 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡